Form 4: NeuroPace Executive Martha Morrell Reports Stock and Option Awards

Chief Medical Officer Martha Morrell reports acquisition of stock and option awards in NeuroPace Inc.

Summary

• Martha Morrell, Chief Medical Officer of NeuroPace Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 24, 2025, Morrell acquired 11,700 shares of common stock represented by restricted stock units (RSUs) at $0.
• Morrell also acquired options to purchase 19,850 shares of common stock at an exercise price of $12.30.
• 25% of the RSUs vest on March 24, 2026, with the remainder vesting in twelve equal quarterly installments.
• 25% of the shares subject to the option vest on March 24, 2026, with the remainder vesting in thirty-six equal consecutive monthly installments.
• Following these transactions, Morrell beneficially owns 90,926 shares of common stock and options for 19,850 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing indicates standard executive compensation practices, suggesting confidence in the company's future.

Positives

• The acquisition of stock and options by a key executive signals confidence in the company's future prospects.

Future Outlook

The vesting schedules for the RSUs and stock options incentivize the executive to remain with the company and contribute to its long-term success.

Industry Context

Form 4 filings are routine disclosures that provide transparency into the trading activities of company insiders, offering insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executive compensation packages including stock options and RSUs are standard practice in the biotechnology and medical device industries.
• Vesting schedules are designed to align executive interests with long-term shareholder value, similar to practices at companies like Medtronic and Boston Scientific.

Stakeholder Impact

• The granting of stock options and RSUs aligns the executive's interests with those of shareholders, potentially driving long-term value creation.

Key Dates

Keywords

Form 4, NeuroPace, Martha Morrell, Stock Options, RSUs, Beneficial Ownership, NPCE, Executive Compensation